Apollon Wealth Management »

Novabay Pharmaceuticals shares owned by Apollon Wealth Management

Quarter-by-quarter ownership of Novabay Pharmaceuticals (NBY) shares owned by Apollon Wealth Management from 13F filings

Historical chart of Apollon Wealth Management investment in Novabay Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Novabay Pharmaceuticals held by Apollon Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novabay Pharmaceuticals by Apollon Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $35k 28k 1.28

More positions owned by Apollon Wealth Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Amazon (AMZN)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Pgim Etf Tr Total Return Bon (PTRB)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Hartford Fds Exchange Traded Core Bd Etf (HCRB)

View all positions for Apollon Wealth Management

Top funds holding Novabay Pharmaceuticals

Vanguard Group
Geode Capital Management
State Street Corporation
Apollon Wealth Management
Ground Swell Capital
Virtu Financial
Tower Research Capital
Morgan Stanley
NVWM
Addison Advisors
Northwestern Mutual Wealth Management Company
Royal Bank of Canada

View all funds holding Novabay Pharmaceuticals